A phase 3, randomised double blind study of Nivolumab Monaotherapy or Nivolumab combined with Ipilimumab versus Ipilimumab monotherapy in subjects with previously untreated unresectable or metastatic

Project: Research

StatusFinished
Effective start/end date20/06/1315/10/14